Becton Dickinson and Co vs JPMorgan Ultra Short Income ETF — how do they compare? Becton Dickinson and Co trades at $154.29 (market cap $42.39B), while JPMorgan Ultra Short Income ETF trades at $50.48. The key difference: Becton Dickinson and Co pays a 2.73% dividend while JPMorgan Ultra Short Income ETF pays none, and Becton Dickinson and Co is trading nearer its 52-week high, JPMorgan Ultra Short Income ETF nearer its low. Which is the better fit depends on your goals.
| BDX | JPST | |
|---|---|---|
Market Cap | $42.39B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $185.39 | $50.78 |
52-Week Low | $135.49 | $50.40 |
Enterprise Value | $58.85B | — |
Dividend Yield | 2.73% | — |
Trailing returns across standard periods
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →